Role of the Microbiome in Gut-Heart-Kidney Cross Talk
Circulation Research · 14.04.2023 · 132 (8) · 1064-1083
DOI: 10.1161/circresaha.123.321763 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 14.04.2023. Verfasst von Griet Glorieux und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Gent, Belgium (G.G., R.V., F.V.). Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Microbiota. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 206 Literaturangaben.
Abstract (Originalsprache)
Homeostasis is a prerequisite for health. When homeostasis becomes disrupted, dysfunction occurs. This is especially the case for the gut microbiota, which under normal conditions lives in symbiosis with the host. As there are as many microbial cells in and on our body as human cells, it is unlikely they would not contribute to health or disease. The gut bacterial metabolism generates numerous beneficial metabolites but also uremic toxins and their precursors, which are transported into the circulation. Barrier function in the intestine, the heart, and the kidneys regulates metabolite transport and concentration and plays a role in inter-organ and inter-organism communication via small molecules. This communication is analyzed from the perspective of the remote sensing and signaling theory, which emphasizes the role of a large network of multispecific, oligospecific, and monospecific transporters and enzymes in regulating small-molecule homeostasis. The theory provides a systems biology framework for understanding organ cross talk and microbe-host communication involving metabolites, signaling molecules, nutrients, antioxidants, and uremic toxins. This remote small-molecule communication is critical for maintenance of homeostasis along the gut-heart-kidney axis and for responding to homeostatic perturbations. Chronic kidney disease is characterized by gut dysbiosis and accumulation of toxic metabolites. This slowly impacts the body, affecting the cardiovascular system and contributing to the progression of kidney dysfunction, which in its turn influences the gut microbiota. Preserving gut homeostasis and barrier functions or restoring gut dysbiosis and dysfunction could be a minimally invasive way to improve patient outcomes and quality of life in many diseases, including cardiovascular and kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Gent, Belgium (G.G., R.V., F.V.).
- Department of Pediatrics (S.K.N.), University of California San Diego, La Jolla, CA.
- Division of Nephrology, Department of Medicine (S.K.N.), University of California San Diego, La Jolla, CA.
ORCID-Profile: Griet Glorieux
Zitieren
APA
Glorieux, G., Nigam, S. K., Vanholder, R., & Verbeke, F. (2023). Role of the Microbiome in Gut-Heart-Kidney Cross Talk. Circulation Research, 132(8), 1064-1083. https://doi.org/10.1161/circresaha.123.321763
Vancouver
Glorieux G, Nigam SK, Vanholder R, Verbeke F. Role of the Microbiome in Gut-Heart-Kidney Cross Talk. Circulation Research. 2023;132(8):1064-1083. doi:10.1161/circresaha.123.321763
BibTeX
@article{Glorieux2023,
author = {Glorieux, Griet and Nigam, Sanjay K and Vanholder, Raymond and Verbeke, Francis},
title = {Role of the Microbiome in Gut-Heart-Kidney Cross Talk},
journal = {Circulation Research},
year = {2023},
volume = {132},
number = {8},
pages = {1064--1083},
doi = {10.1161/circresaha.123.321763}
}
EUVIMED